- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
HotSpot Therapeutics heats up with $100m
Merck & Co and SR One were among the investors in a series C round for the small molecule drug developer led by Pivotal BioVenture Partners.
Dec 1, 2021Quantum jeopardy and the march of artificial intelligence
From applications in clinical areas such as diagnostics and drug discovery, to the chemical, manufacturing, retail and automotive sectors, artificial intelligence (AI) technologies have disrupted many traditional industries, opening new frontiers and driving the development of ground-breaking solutions.
Dec 1, 2021AI disruption creates venture chances
AI Q4 2021 report editorial by James Mawson, editor in chief, Global Corporate Venturing
Dec 1, 2021Abogen accesses $300m
The vaccine developer's series C-plus round was co-led by SoftBank Vision Fund and came just three months after it closed a $700m series C.
Nov 30, 2021Legend Capital lets in $177m for healthcare fund
The Legend Holdings-formed venture capital firm is reportedly seeking $300m for the final close of its latest dollar-denominated healthcare vehicle.
Nov 30, 2021Deals: November 30, 2021
Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Nov 30, 2021Ablaze Pharmaceuticals catches alight with $75m
Radiotherapy developer RayzeBio has spun off a China-focused subsidiary called Ablaze with series A funding from investors also including Nan Fung.
Nov 30, 2021Deals: November 29, 2021
Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Nov 29, 2021Lunit lassoes corporates to raise $61m
The medical technology developer increased its total funding to over $135m in a round backed by Naver, NSG Ventures, Kakao Ventures and SoftBank Ventures Asia.
Nov 29, 2021Quell eases into $156m series B
Syncona has returned for an oversubscribed round that will allow Quell Therapeutics to fund a clinical trial, advance its pipeline and accelerate platform development.
Nov 29, 2021Daily Deal Round Up: November 26, 2021
Fosun RZ Capital returned to reinvest in e-commerce software provider Desty through a $5m series A round while inventory management software developer Smart Shopping boosted its total funding to $14m.
Nov 26, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
